Karl Thomas
Karl Thomas Geiringen, Auckland NZ
Patent application number | Description | Published |
---|---|---|
20100069492 | PRODUCTION OF ULTRAPURE EPA AND POLAR LIPIDS FROM LARGELY HETEROTROPHIC CULTURE - Eicosapentaenoic acid (EPA) compositions and EPA-rich polar lipids for prophylactic or therapeutic applications are described. Production from certain cultured micro-organisms (like | 03-18-2010 |
Karl Thomas Geiringer, Wellington NZ
Patent application number | Description | Published |
---|---|---|
20130131173 | COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID SUITABLE FOR HIGH PURIFICATION - The invention relates to a microbial biomass composition produced from a heterotrophic fermentation whose fatty acid profile exhibits: an eicosapentaenoic acid (EPA) to arachidonic acid (ARA) ratio of about 11:1 or more; an EPA to total co-concentrating fatty acid ratio of about 8:1 or more, extract compositions, and methods of producing such compositions. | 05-23-2013 |
Karl Thomas Geiringer, Waitakere NZ
Patent application number | Description | Published |
---|---|---|
20140295529 | COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID SUITABLE FOR HIGH PURIFICATION - The invention relates to a microbial biomass composition produced from a heterotrophic fermentation whose fatty acid profile exhibits an eicosapentaenoic acid (EPA) to arachidonic acid (ARA) ratio of about 11:1 or more, an EPA to total co-concentrating fatty acid ratio of about 8:1 or more, extract compositions, and methods of producing such compositions. | 10-02-2014 |
Karl Thomas Geiringer, Auckland NZ
Patent application number | Description | Published |
---|---|---|
20150057353 | production of ultrapure EPA and polar lipids form largely heterotrophic culture - Eicosapentaenoic acid (EPA) compositions and EPA-rich polar lipids for prophylactic or therapeutic applications are described. Production from certain cultured micro-organisms (like | 02-26-2015 |
Karl Thomas Ried, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20110224089 | GENE EXPRESSION SIGNATURE OF GENOMIC INSTABILITY IN BREAST CANCER - Methods of assessing genomic instability in breast cancer tissue by measuring the expression level of genes CDKN2A, SCYA18, STK15, NXF1, cDNA Dkfzp762M127, p28 KIAA0882, MYB, Human clone 23948, RERG, HNF3A, and ACADSB or a nucleic acid sequence comprising about 90% or greater sequence identity to SEQ ID NO: 21 in breast cancer tissue, an array suitable for use in such methods, and related methods and compositions. | 09-15-2011 |
Karl Thomas Schuetze, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20140210289 | APPARATUS AND METHODS FOR PASSIVE MAGNETIC REDUCTIONOF THRUST FORCE IN ROTATING MACHINES - Apparatus and methods for providing a pre-determined axial thrust force profile for use in a rotating machine that includes a magnetically permeable rotor with first and second surfaces and a generally perpendicular shaft is disclosed. One or more bearings support the shaft and a coil induces flux in the rotor. First and second pole pieces disposed adjacent to the first and second surfaces define first and second gaps. A series magnetic circuit including the pole pieces, the gaps and the rotor carries flux generated by current flowing in the coil. Pole pieces and gaps provide substantially similar reluctance in both gaps. Magnetic saturation characteristics of a series magnetic circuit may provide a pre-determined axial force profile as a function of coil current. A first magnetic saturation characteristic may provide a maximum axial force at a first current magnitude. A second magnetic saturation characteristic may provide a lower axial force at a current greater than the first current. The saturation characteristic may be formed by configuring the geometry and dimensions of the poles. The axial force profile may be formed to reduce the net axial thrust load on the bearings. | 07-31-2014 |